High Content and Phenotypic Screening 2017

The development of techniques and tools implemented in High Content technologies and Phenotypic Screening applications will be discussed at this SELECTBIO meeting. Topics for discussion include 3D cell based screening methods, high content screening and data management, the use of model organisms and novel approaches for phenotypic screening. Speakers include as Keynotes: - Leo Price, CEO, OcellO B.V - Lorenz Mayr, Vice President, AstraZeneca Ltd - Jeffrey Morgan, Professor, Brown University Attending this event will provide you with excellent opportunities for networking with attendees from big pharmaceutical and biotech companies, academia and government, helping you to find solutions and build collaborations. Visit the website for up-to-date information, including poster submissions, and registration details.